Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography-Reference-Cited by-同舟云学术

Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography

Published:2016-02 Issue:2 Volume:45 Page:198-203
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Yamada Suguru,Fujii Tsutomu,Suzuki Kojiro,Inokawa Yoshikuni,Kanda Mitsuro,Nakayama Goro,Sugimoto Hiroyuki,Koike Masahiko,Nomoto Shuji,Fujiwara Michitaka,Nakao Akimasa,Kodera Yasuhiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.;Raymond;N Engl J Med,2011

2. Revised classification of neuroendocrine tumours of the lung, pancreas and gut.;Capella;Virchows Arch,1995

3. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.;Madeira;Gut,1998

4. Prognostic criteria in nonfunctioning pancreatic endocrine tumours.;La Rosa;Virchows Arch,1996

5. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors.;Gentil Perret;Am J Clin Pathol,1998

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel endoscopic ultrasomics-based machine learning model and nomogram to predict the pathological grading of pancreatic neuroendocrine tumors;Heliyon;2024-07

2. Tumor vascularity on contrast-enhanced computed tomography as a predictive marker of metastatic potential for small nonfunctioning pancreatic neuroendocrine tumors;Surgery;2024-02

3. Neuroendocrine Neoplasms;Tumors of the Pancreas;2023-03

4. Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms;World Journal of Gastroenterology;2022-07-14

5. Prognostic value of CT characteristics in GEP-NET: A systematic review;Critical Reviews in Oncology/Hematology;2022-07